Targeting CD70 with cusatuzumab eliminates acute myeloid leukemia stem cells in patients treated with hypomethylating agents
Carsten Riether, Thomas Pabst, Sabine Höpner, Ulrike Bacher, Magdalena Hinterbrandner, Yara Banz, Rouven Müller, Markus G. Manz, Walid H. Gharib, David Miguel Ferreira Francisco, Rémy Bruggmann, Luc Van Rompaey, Mahan Moshir, Tim Delahaye, Domenica Gandini, Ellen Erzeel, Anna Hultberg, Samson Fung, Hans de Haard, Nicolas Leupin, Adrian F. Ochsenbein
Topics & Concepts
AzacitidineMyeloid leukemiaMedicineHypomethylating agentMinimal residual diseaseLeukemiaInternal medicineOncologyMyeloidFlow cytometryImmunologyChemotherapyBiologyGene expressionGeneBiochemistryDNA methylationAcute Myeloid Leukemia ResearchImmune cells in cancerHematopoietic Stem Cell Transplantation